Bronfman M, Orellana A, Morales M N, Bieri F, Waechter F, Stäubli W, Bentley P
Faculty of Biological Sciences, P. Universidad Catolica de Chile, Santiago.
Biochem Biophys Res Commun. 1989 Mar 31;159(3):1026-31. doi: 10.1016/0006-291x(89)92211-0.
Acyl-Coenzyme A thioesters of the hypolipidaemic and cancerinogenic peroxisome proliferators clofibric acid, nafenopin, ciprofibrate, bezafibrate and tibric acid were found to greatly increase the activity of rat brain protein kinase C. Maximal activation required the simultaneous presence of Ca+2, phosphatidylserine and diolein, thus differentiating their action from that of other tumor promoters such as phorbol esters. Under similar conditions the unesterified drugs were comparatively ineffective. Similar results were obtained using the rat liver enzyme. The data suggest that acylcoenzyme A thioesters of hypolipidaemic drugs, may play a role in the induction of liver tumors by these compounds, through the potentiation of protein kinase C.
降血脂和致癌的过氧化物酶体增殖剂氯贝酸、萘酚平、环丙贝特、苯扎贝特和替贝特的酰基辅酶A硫酯被发现能极大地提高大鼠脑蛋白激酶C的活性。最大激活需要同时存在Ca+2、磷脂酰丝氨酸和二油精,因此它们的作用与其他肿瘤促进剂如佛波酯不同。在类似条件下,未酯化的药物相对无效。使用大鼠肝脏酶也得到了类似的结果。数据表明,降血脂药物的酰基辅酶A硫酯可能通过增强蛋白激酶C,在这些化合物诱导肝肿瘤中发挥作用。